Last update 15 Aug 2026

BWC-2094

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
BWC 2094, BWC2094
Target
A2aR x A2bR x SLC29A1
Action
antagonists, inhibitors
Mechanism
A2aR antagonists(Adenosine A2a receptor antagonists), A2bR antagonists(Adenosine A2b receptor antagonists), SLC29A1 inhibitors(solute carrier family 29 member 1 (Augustine blood group) inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEndocrinology and Metabolic Disease+ [3]
Active Indication
Colorectal CancerNon-Small Cell Lung CancerOvarian Cancer+ [5]
Inactive Indication-
Originator Organization
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
Active Organization
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with BWC-2094
Login to view more data
100 Translational Medicine associated with BWC-2094
Login to view more data
100 Patents (Medical) associated with BWC-2094
Login to view more data
100 Deals associated with BWC-2094
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Colorectal CancerPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Non-Small Cell Lung CancerPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Ovarian CancerPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Pancreatic CancerPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Prostatic CancerPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Renal Cell CarcinomaPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Squamous Cell Carcinoma of Head and NeckPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Triple Negative Breast CancerPreclinical
India
BUGWORKS Research, Inc.BUGWORKS Research, Inc.
01 Aug 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free